Brampton, Canada Clinical Trials

A listing of Brampton, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 129 clinical trials
None
INSIGHT (Insight Into Nephrotic Syndrome)

INSIGHT is a longitudinal study of childhood nephrotic syndrome to determine genetic, serologic and environmental factors contributing to nephrotic syndrome and disease progression.

William Osler Health System, Brampton Civic Hospital
 (1.6 away) Contact site
  • 148 views
  • 21 Mar, 2021
  • +4 other locations
None
Canadian Children Inflammatory Bowel Disease Network (CIDsCANN)

The initial network clinical study will be an inception cohort study in children with new onset IBD (Inflammatory Bowel Disease) rigorously phenotyped and prospectively followed. Focusing on a prospective, inception cohort of Canadian children of widely varied racial origins provides a unique opportunity to explore environmental risk factors early in …

inflammatory bowel disease
ulcerative colitis
intestinal diseases
ulceration
crohn's disease
William Osler Health System
 (1.6 away) Contact site
  • 73 views
  • 16 Feb, 2021
  • +12 other locations
None
Psoriasis Longitudinal Assessment and Registry

The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported …

interleukin-17
guselkumab
cyclosporine
psoralen
infliximab
Manna Research
 (9.4 away) Contact site
  • 4062 views
  • 01 Dec, 2021
  • +494 other locations
None
Pan-Canadian Lung Cancer Observational Study (PALEOS)

This study is a multicenter, ambispective observational study that will collect data focusing on patients with lung cancers in Canada. The study will begin with ALK, EGFR, ROS1, ERBB2 (HER2), exon 20 EGFR mutation, MET and BRAF patients, with the goal of expanding into other rare molecular alterations within year …

William Osler Health System - Brampton Civic Hospital
 (1.6 away) Contact site
  • 0 views
  • 02 Feb, 2021
  • 1 location
None
Canadian Medical Assessment of JINARC Outcomes Registry

This study is part of the Health Canada approval requirement for tolvaptan and is an observational, non-interventional study (NIS) describing the impact of tolvaptan on ADPKD-related burden of illness as measured with a set of Patient Reported Outcome (PRO) Questionnaires. The study is also describing the time to renal replacement …

 (11.4 away) Contact site
  • 3393 views
  • 27 Jan, 2021
  • +18 other locations
None
Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice

A study to assess the real-life management and use of healthcare resources during the initiation of: Venetoclax in combination with rituximab is indicated for the treatment of adult participants with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy. Venetoclax in participants with CLL with the deletion …

lymphoid leukemia
rituximab
venetoclax
chronic lymphocytic leukemia
William Osler Health System /ID# 202049
 (1.6 away) Contact site
  • 123 views
  • 06 Sep, 2021
  • +17 other locations
None
Host Response Mediators in Coronavirus (COVID-19) Infection

The coronavirus (COVID-19) pandemic continues to grow exponentially. Angiotensin II levels are increased in human influenza and are associated with influenza viral load, disease progression and mortality. Preliminary data shows angiotensin II receptor blockers (ARBs) limits lung injury in murine influenza H7N9, as well as viral titre and RNA. ARBs …

lung injury
covid-19
coronavirus infection
angiotensin
ace inhibitor
Humber River Hospital
 (17.6 away) Contact site
  • 303 views
  • 24 Jan, 2021
  • +14 other locations
None
A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. This study will assess how effective Upadacitinib is in changing the disease symptoms in Canadian participants with RA. Upadacitinib is a drug approved for the treatment of moderately to severely active …

DMARD
antirheumatics
stiffness
Drs. Rai & Sekhon MPC /ID# 224366
 (1.8 away) Contact site
  • 109 views
  • 02 Nov, 2021
  • +53 other locations
None
Golimumab for Adherence in Rheumatoid Arthritis

The purpose of this study is to determine if non-adherence to Rheumatoid Arthritis (RA) drugs in participants treated with biologic disease modifying anti-rheumatic drugs (DMARDs) is associated with a greater incidence of disease in clinical practice.

golimumab
DMARD
rheumatic diseases
antirheumatics
Dr. Sangeetha Thiviyarajah Medicine Professional Corporation
 (7.9 away) Contact site
  • 189 views
  • 02 Dec, 2021
  • +37 other locations